Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: The combination of methotrexate and cytosine arabinoside in newly diagnosed adult Langerhans cell histiocytosis: a prospective phase II interventional clinical trial

Fig. 3

Survival of adult patients with LCH. a The overall EFS of the entire group in our study. b The overall survival of the entire group in our study. c The EFS of adult patients with and without risk organ involvement. The diamond represents group with risk organ involvement, while the square represents the group without risk organ involvement, including the multi-system disease and single system disease. d The EFS of adult patients with multi-system disease with and without risk organ involvement. The diamond represents MS-RO+ group, while the square represents the MS-RO- group

Back to article page